Trials / Completed
CompletedNCT05615155
Efficacy of C-PRF vs i-PRF in Thin Gingival Biotype Subjects
Efficacy of C-PRF Versus i-PRF on Gingival Thickness & Keratinized Tissue Width in Subjects With Thin Gingival Biotype: ( Split Mouth Controlled Clinical Trials)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Sajjad Ahmed Shakir · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Randomized split mouth clinical trials study focused on comparing the efficacy of i-prf versus c-prf injections on gingival thickness and keratinized tissue width in subjects with thin gingival biotype.
Detailed description
Randomized split mouth clinical trials study focused on comparing the efficacy of i-prf versus c-prf injections on gingival thickness and keratinized tissue width in subjects with thin gingival biotype. Gingival biotype is an important clinical parameter that plays an important role in determining the gingival health in the future and the possibility of developing gingival recession or other gingival unhealthy condition that is related to thin gingival biotype. Gingival biotype is consist of gingival thickness and keratinized tissue width, and its either thin or thick, and the later is more favourable to withstand the developing of gingival diseases and unhealthy condition, with this study we compare the effect of i-PRF injection which is approved in many previous clinical trials that it affects the gingival biotype and increases gingival thickness and the keratinized tissue width, and compare it to newly developed PRF generation (C-PRF) which is Concentrated Platelet Rich Fibrin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Platelets Rich Fibrin (i-PRF / C-PRF) | one site of the mouth will be injected with i-PRF and the other site will be injected with C-PRF |
Timeline
- Start date
- 2022-02-01
- Primary completion
- 2022-11-01
- Completion
- 2022-11-01
- First posted
- 2022-11-14
- Last updated
- 2023-11-28
Locations
1 site across 1 country: Iraq
Source: ClinicalTrials.gov record NCT05615155. Inclusion in this directory is not an endorsement.